Imatinib mesylate exerts anti-proliferative effects on osteosarcoma cells and inhibits the tumour growth in immunocompetent murine models
about
Present Advances and Future Perspectives of Molecular Targeted Therapy for OsteosarcomaReceptor tyrosine kinases: Characterisation, mechanism of action and therapeutic interests for bone cancersExploring targeted therapy of osteosarcoma using proteomics dataEGFR is not a major driver for osteosarcoma cell growth in vitro but contributes to starvation and chemotherapy resistance.Synergistic antiproliferative effect of imatinib and adriamycin in platelet-derived growth factor receptor-expressing osteosarcoma cells.Targeting protein kinases to reverse multidrug resistance in sarcoma.Mesenchymal stem cells increase proliferation but do not change quiescent state of osteosarcoma cells: Potential implications according to the tumor resection statusEffects of the overexpression of IFITM5 and IFITM5 c.-14C>T mutation on human osteosarcoma cells.Noscapine targets EGFR(p-Tyr1068) to suppress the proliferation and invasion of MG63 cells.Apoptosis prediction via inhibition of AKT signaling pathway by neogrifolin.HSP70 desensitizes osteosarcoma cells to baicalein and protects cells from undergoing apoptosis.Histology-Specific Uses of Tyrosine Kinase Inhibitors in Non-gastrointestinal Stromal Tumor Sarcomas.Influence of ezrin-shRNA in combination with HSP70 on the apoptosis and proliferation of osteosarcoma cells.PDGF/PDGFR effects in osteosarcoma and the "add-on" strategy
P2860
Q26750631-18368C0B-E889-49EC-87D1-73C8B33AC359Q28082793-7DA27D67-D7B4-4EFA-92B8-F4CD6C0A77DDQ28817274-F0BAE880-F2F5-4D6E-9E14-B7666EC9A7C2Q35829712-3F5F618C-1E1A-4374-A1D0-FA892FB6C80BQ35904214-206D7ABB-4C1A-4B53-A207-879DF2F87188Q36527950-4FBB03F8-377E-48E9-AE9A-D0743171665EQ36661456-C619A298-EAA2-4312-A9D9-FA4217D7B2F0Q37594020-FFFDE270-5DEE-412A-A431-9AB662A3E031Q38731969-BF75F401-5748-498C-A773-B58C71F105C3Q38875159-1FA22201-9C31-48B7-8FF3-8D00588D5959Q38993208-5AFCE61C-0EB4-468C-AA41-42EC2F07298EQ39956277-8E223208-65F4-442D-970A-B3F8C71FA376Q42370628-1D14EAA3-12F9-4D24-A799-05ED091E43E3Q58803894-A5C61D1C-2EB0-4461-A72E-6DA2BD039B4C
P2860
Imatinib mesylate exerts anti-proliferative effects on osteosarcoma cells and inhibits the tumour growth in immunocompetent murine models
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Imatinib mesylate exerts anti- ...... immunocompetent murine models
@ast
Imatinib mesylate exerts anti- ...... immunocompetent murine models
@en
Imatinib mesylate exerts anti- ...... immunocompetent murine models
@nl
type
label
Imatinib mesylate exerts anti- ...... immunocompetent murine models
@ast
Imatinib mesylate exerts anti- ...... immunocompetent murine models
@en
Imatinib mesylate exerts anti- ...... immunocompetent murine models
@nl
prefLabel
Imatinib mesylate exerts anti- ...... immunocompetent murine models
@ast
Imatinib mesylate exerts anti- ...... immunocompetent murine models
@en
Imatinib mesylate exerts anti- ...... immunocompetent murine models
@nl
P2093
P2860
P3181
P1433
P1476
Imatinib mesylate exerts anti- ...... immunocompetent murine models
@en
P2093
Benjamin Ory
Bérengère Gobin
Céline Charrier
Françoise Redini
Gatien Moriceau
Régis Brion
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0090795
P407
P577
2014-01-01T00:00:00Z